Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021

HomeCSA MedicalRejuvenAir® System for COPD Patients with Chronic Bronchitis Earns CE Mark

RejuvenAir® System for COPD Patients with Chronic Bronchitis Earns CE Mark

Today CSA Medical announced that it has received CE Mark approval for its RejuvenAir® System for the treatment of Chronic Obstructive Pulmonary Disease (COPD) with Chronic Bronchitis (CB). The RejuvenAir System is a revolutionary cryosurgical device which applies Metered Cryospray (“MCS”) of liquid nitrogen at -196◦C to targeted areas within the lungs through a minimally invasive bronchoscopic procedure. The extreme cold flash freezes damaged surface area lung cells which induces a rejuvenative healing process.

COPD with CB is a long-term, progressive lung disease that, over time, makes it hard to breathe.  CB is characterized by a productive cough due to the overproduction of mucus and damaged cilia. According to the American Lung Association, CB affects more than 11 million Americans and is the third leading cause of disease-related deaths.

“While pharmaceutical options can decrease cough and mucus production, the RejuvenAir System offers the only treatment able to address the underlying cause of CB – while simultaneously treating the debilitating symptoms,” says Heather Nigro, SVP of Regulatory, Quality and Clinical Affairs at CSA Medical. She continued, “This patient population now has an option that can dramatically improve their quality of life – that’s exciting!”

The approval in the EU of this first-of-a-kind technology was supported by a prospective, multi-center, open-label, safety and efficacy study. The 35 patient study led to a significant improvement in patient-reported health-related quality of life, at least up to 12 months. Treatment with the RejuvenAir System was well tolerated and did not result in any significant or unexpected safety events.

“RejuvenAir Metered Cryospray can be safely delivered in patients with COPD and demonstrates clinical meaningful improvements in quality of life and patient-reported outcome scores out to 12 months,” said Professor Pallav Shah, M.D., F.R.C.P. from the Royal Brompton, London. “This is a promising new therapy for the millions of people who suffer from chronic bronchitis.”

The RejuvenAir® Metered CryosprayTM System is designed to spray liquid nitrogen at -196◦C in a circumferential pattern within the airway. It is anticipated that the rapid freezing of the epithelial layer of the airway walls will destroy the mucus-producing goblet cells while preserving the extracellular matrix, thereby enabling the regrowth of healthy cells. The RejuvenAir® System is now approved in the EU and under clinical investigation in the United States.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

By using this website you agree to accept Medical Device News Magazine Privacy Policy